Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The systemic inflammatory cytokine network is a sophisticated communication system composed of various signaling proteins, including interleukins, interferons, and tumor necrosis factors, that regulate the immune system's response to pathogens and tissue damage (Fajgenbaum & June, 2020, NEJM). This network operates through complex feedback loops where cytokines can induce or inhibit the production of one another, ensuring a balanced inflammatory response (Dinarello, 2000, Chest). Pathological overactivation of this network, often termed a 'cytokine storm,' is a hallmark of severe conditions such as sepsis, CAR-T cell therapy-induced cytokine release syndrome, and severe viral infections (Tanaka et al., 2014, CSH Perspect Biol). Pharmacological strategies do not target the network as a single entity but rather focus on specific high-impact nodes, such as IL-6 or TNF-alpha, to alleviate systemic inflammation (Choy, 2012, Nat Rev Rheumatol). Understanding the temporal and spatial dynamics of this network is crucial for developing precision therapies that can resolve inflammation while preserving essential immune functions (Schett et al., 2013, Nat Rev Immunol).
Modulation of the network occurs through the inhibition of specific pro-inflammatory cytokines (e.g., TNF-alpha, IL-6, IL-1) or their receptors, as well as the inhibition of downstream intracellular signaling pathways like the JAK/STAT pathway (Choy, 2012, Nat Rev Rheumatol; Schett et al., 2013, Nat Rev Immunol).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic inflammatory cytokine network.